Krueger Christopher W

Christopher W. Krueger serves as the Chief Business Officer at Ventyx Biosciences, Inc., a company focused on innovative healthcare solutions. His recent trading activity, tracked through SEC Form 4 filings, shows a pattern of sale transactions from December 19, 2023, to April 3, 2024, involving the company's stock, VTYX. During this period, he reported six disclosures, primarily consisting of sales ranging from $8.9K to $11.2K, with a notable grant/exercise transaction valued at approximately $387.9K on December 19, 2023.